Science Explorer Back to mapMap
Discussion
Researcher · Immunovative Therapies (Israel) · Israel

Michael Har-Noy

Michael Har-Noy publishes mostly in Immunology, Oncology and Epidemiology, on topics such as Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and Immune Cell Function and Interaction.

ORCID 0000-0002-9342-9337 OpenAlex
World rank
#4,488,594
of 7,710,434 ranked researchers
Rank in Israel
#27,407
of 38,292
Works
25
Citations
415
Citations per work
16.6
h-index
8
i10-index 8Top 85% in Immunology
Michael Har-Noy

What does Michael Har-Noy research?

Michael Har-Noy's work is mostly in Medicine (43%), Immunology and Microbiology (33%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 11 works · 42.7% of their workMedicine: 11 works · 42.7% of their workOncology: 6 works · 24.0% of their workEpidemiology: 2 works · 8.0% of their workSurgery: 2 works · 6.7% of their workHepatology: 1 works · 4.0% of their workLife Sciences: 9 works · 37.3% of their workImmunology and Microbiology: 8 works · 33.3% of their workImmunology: 8 works · 33.3% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 4.0% of their workBiotechnology: 1 works · 4.0% of their workEverything else: 5 works · 20.0% of their workTHEIR WORKMichael Har-Noy25works
Life Sciences37%Health Sciences43%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1142.7%
    1. Immunology and Microbiology833.3%
    2. Biochemistry, Genetics and Molecular Biology14.0%
  3. Everything else520.0%
  1. 1Immunology33% of their works
  2. 2Oncology24% of their works
  3. 3Epidemiology8% of their works
  4. 4Surgery7% of their works
  5. 5Hepatology4% of their works
  6. 6Biotechnology4% of their works

Research topics

Which keywords describe Michael Har-Noy's research?

The keywords of their largest research topics: Dendritic Cells, Immune Checkpoint Blockade, Immunity, PD-1 and PD-L1, Natural Killer Cells, NK Cell Recognition, Cetuximab and Foxp3.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Dendritic Cells101 topic
  2. Immune Checkpoint Blockade101 topic
  3. Immunity101 topic
  4. PD-1 and PD-L1101 topic
  5. NK Cell Recognition71 topic
  6. Natural Killer Cells71 topic
  7. Cetuximab41 topic
  8. Foxp341 topic
  9. KRAS Mutations41 topic
  10. TGF-ß41 topic
  11. Bacterial Therapy31 topic
  12. Hepatocellular Carcinoma31 topic
  13. Human Metapneumovirus31 topic
  14. Liver Cancer31 topic
  15. Respiratory Syncytial Virus31 topic
  16. Tumor Targeting31 topic

Where does Michael Har-Noy work?

Michael Har-Noy's main affiliation in the publication record is Immunovative Therapies (Israel), Israel.

How many publications and citations does Michael Har-Noy have?

OpenAlex counts 25 works and 415 citations for Michael Har-Noy, an h-index of 8, ranking #4,488,594 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael Har-Noy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.